Toledano Miranda Jayne 4
4 · Entera Bio Ltd. · Filed Sep 9, 2022
Insider Transaction Report
Form 4
Entera Bio Ltd.ENTX
Toledano Miranda Jayne
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-09-07+500,000→ 500,000 totalExercise: $2.02Exp: 2032-05-16→ Ordinary Shares, par value NIS 0.0000769 per share (500,000 underlying) - Award
Stock Option (right to buy)
2022-09-07+600,000→ 600,000 totalExercise: $1.40Exp: 2032-07-15→ Ordinary Shares, par value NIS 0.0000769 per share (600,000 underlying)
Footnotes (2)
- [F1]This grant of options was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on May 11, 2022, subject to approval by the Company's shareholders, which was obtained on September 7, 2022. The options vest over a four-year period that commenced on May 16, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
- [F2]This grant of options was approved by the Board on July 15, 2022, subject to approval by the Company's shareholders, which was obtained on September 7, 2022. The options vest over a four-year period that commenced on July 15, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.